| Date | Time | Source | Headline | Symbol | Company |
| 03/11/2024 | 5:22PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 03/11/2024 | 9:55AM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 03/11/2024 | 9:51AM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 03/11/2024 | 9:49AM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 03/11/2024 | 9:46AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 03/11/2024 | 9:44AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 03/11/2024 | 9:42AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 03/11/2024 | 9:40AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 03/11/2024 | 9:37AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 03/11/2024 | 9:36AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 03/11/2024 | 9:32AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 03/11/2024 | 8:47AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 03/08/2024 | 4:04PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 02/28/2024 | 7:37AM | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 02/28/2024 | 7:34AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 02/22/2024 | 8:32AM | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 02/22/2024 | 8:31AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 02/08/2024 | 7:00AM | Edgar (US Regulatory) | Form DEFM14A - Definitive proxy statement relating to merger or acquisition | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 02/06/2024 | 4:15PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 01/29/2024 | 4:52PM | Edgar (US Regulatory) | Form PREM14A - Preliminary proxy statements relating to merger or acquisition | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 01/29/2024 | 4:28PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 01/10/2024 | 3:07PM | PR Newswire (US) | Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law Firm | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 01/09/2024 | 6:12AM | IH Market News | Wall Street Highlights: HPE and Juniper Networks in Negotiations, Elliott Invests $1 Billion in Match Group, and More | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 01/08/2024 | 5:20PM | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 01/08/2024 | 5:16PM | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 01/08/2024 | 8:04AM | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 01/08/2024 | 8:01AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 01/08/2024 | 7:30AM | Business Wire | Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 01/05/2024 | 5:04PM | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:HARP | Harpoon Therapeutics Inc |
| 12/26/2023 | 7:30AM | GlobeNewswire Inc. | Harpoon Therapeutics Strengthens Leadership Team | NASDAQ:HARP | Harpoon Therapeutics Inc |